Literature DB >> 11463109

A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay.

P Druilhe1, A Moreno, C Blanc, P H Brasseur, P Jacquier.   

Abstract

We report a double-site enzyme-linked lactate dehydrogenase immunodetection assay (DELI), a highly sensitive antigen-capture enzyme-linked immunosorbent assay, which proved to be more sensitive for the detection of Plasmodium falciparum than thick blood smears, as sensitive as the polymerase chain reaction, and probably more reliable. This technique can help to detect infra-microscopic parasitemias (one parasite in 10(6)-10(8) red blood cells) from biological samples, and being quantitative, provide a fast substitute to thick smears for epidemiologic purposes. The technique can also be used to measure the in vitro drug sensitivity of P. falciparum with greater ease, much greater speed, and simpler equipment than that required for the isotopic microtest. Results obtained with four antimalarial drugs upon 16 strains closely paralleled those obtained by the isotopic assay (R = 0.95). In contrast with the latter, much lower parasite densities could be tested in the DELI assay (as low as 0.005%), thereby extending the number of isolates that can be investigated. The ease of implementation and low cost of the DELI-microtest may contribute to a revived interest in using in vitro methods to survey resistance to antimalarial drugs, so as to better predict future in vivo drug failures and provide public health recommendations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11463109     DOI: 10.4269/ajtmh.2001.64.233

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  51 in total

1.  Histidine-rich protein II: a novel approach to malaria drug sensitivity testing.

Authors:  Harald Noedl; Walther H Wernsdorfer; Robert Scott Miller; Chansuda Wongsrichanalai
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.

Authors:  A Moreno; E Badell; N Van Rooijen; P Druilhe
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 3.  History, dynamics, and public health importance of malaria parasite resistance.

Authors:  Ambrose O Talisuna; Peter Bloland; Umberto D'Alessandro
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

4.  Field evaluation of a novel colorimetric method--double-site enzyme-linked lactate dehydrogenase immunodetection assay--to determine drug susceptibilities of Plasmodium falciparum clinical isolates from northwestern Thailand.

Authors:  Alan Brockman; Sittaporn Singlam; Lucy Phiaphun; Sornchai Looareesuwan; Nicholas J White; François Nosten
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

5.  Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing.

Authors:  Harald Noedl; Jan Bronnert; Kritsanai Yingyuen; Bernhard Attlmayr; Herwig Kollaritsch; Mark Fukuda
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Plasmodium falciparum in vitro susceptibility to antimalarial drugs in Casamance (southwestern Senegal) during the first 5 years of routine use of artesunate-amodiaquine.

Authors:  P Agnamey; P Brasseur; P Eldin de Pecoulas; Michel Vaillant; P Olliaro
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

7.  Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.

Authors:  Jacob D Johnson; Richard A Dennull; Lucia Gerena; Miriam Lopez-Sanchez; Norma E Roncal; Norman C Waters
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

8.  Shelf life of predosed plates containing mefloquine, artemisinin, dihydroartemisinin, and artesunate as used for in vitro Plasmodium falciparum susceptibility assessment.

Authors:  Sandrine Houzé; Aline Munier; Xavier Paoletti; Halima Kaddouri; Pascal Ringwald; Jacques Le Bras
Journal:  J Clin Microbiol       Date:  2007-06-06       Impact factor: 5.948

9.  Plasmodium falciparum: development of a transgenic line for screening antimalarials using firefly luciferase as the reporter.

Authors:  Long Cui; Jun Miao; Jiaxu Wang; Qianjun Li; Liwang Cui
Journal:  Exp Parasitol       Date:  2008-05-29       Impact factor: 2.011

10.  Antimalarial activity of a cis-terpenone.

Authors:  D C Ghislaine Mayer; Maimuna Bruce; Olga Kochurova; Jennifer K Stewart; Qibing Zhou
Journal:  Malar J       Date:  2009-06-25       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.